Device Consortium Addresses Barriers To Early U.S. Feasibility Studies, MDIC’s Murray Tells Congress
This article was originally published in The Gray Sheet
Executive Summary
Medical Device Innovation Consortium President and CEO Bill Murray testified about MDIC and FDA’s plans to promote early feasibility studies of products in the U.S., rather than abroad, at a recent House Energy and Commerce panel hearing.
You may also be interested in...
AIM Act Touted As One Solution To Device Reimbursement Woes
The Accelerating Innovation in Medicine Act, introduced last year with some bipartisan support, was touted at the latest House 21st Century Cures hearing as a self-pay path for seniors to get access to newly-approved devices not yet covered under Medicare, and to give manufacturers time to collect needed data to support reimbursement.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.